Back to Trades
Taylor Andrew Lawrence
Chief Financial OfficerCIK 0001723889
Profile
- Filings
- 6
- Buy transactions
- 1
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Taylor Andrew Lawrence, Chief Financial Officer, has filed 6 SEC reports (2025–2026), all concentrated in Orchestra BioMed Holdings, Inc. (OBIO), totaling $243.6K in disclosed volume. Weighing $5.1K bought versus $0 sold, the history is heavily weighted toward buying. The largest single open-market purchase on record is $5.1K in Orchestra BioMed Holdings, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Jun 12 | OBIO Orchestra BioMed Holdings, Inc. | Taylor Andrew Lawrence | Chief Financial Officer | Tax withheld | $146.1K |
| May 29 | OBIO Orchestra BioMed Holdings, Inc. | Taylor Andrew Lawrence | Chief Financial Officer | Tax withheld | $12.2K |
| Dec 12 | OBIO Orchestra BioMed Holdings, Inc. | Taylor Andrew Lawrence | Chief Financial Officer | Tax withheld | $40.5K |
| Sep 19 | OBIO Orchestra BioMed Holdings, Inc. | Taylor Andrew Lawrence | Chief Financial Officer | Tax withheld | $39.6K |
| Aug 25 | OBIO Orchestra BioMed Holdings, Inc. | Taylor Andrew Lawrence | Chief Financial Officer | Buy | $5.1K |
| Aug 8 | OBIO Orchestra BioMed Holdings, Inc. | Taylor Andrew Lawrence | Chief Financial Officer | Grant | $0 |
6 filings